Literature DB >> 19533521

Reliability and validity of quantitative sensory testing in persons with spinal cord injury and neuropathic pain.

Elizabeth R Felix1, Eva G Widerström-Noga.   

Abstract

Quantitative sensory testing (QST) has been used to assess neurological function in various chronic pain patient populations. In the present study, we investigated the ability of QST to reliably characterize somatosensory dysfunction in subjects with spinal cord injury (SCI) and neuropathic pain by measuring mechanical, vibration, and thermal detection and pain thresholds. Test-retest reliability was determined based on data collected from 10 subjects with SCI and neuropathic pain who underwent QST on two occasions approximately 3 weeks apart. The intraclass correlation coefficients for mechanical, vibration, warm, and cool detection thresholds were in the "substantial" range, while thresholds for cold pain and hot pain demonstrated "fair" stability in this sample of patients. To determine the validity of QST in persons with SCI-related neuropathic pain, we evaluated the relationship between somatosensory thresholds and severity of neuropathic pain symptoms with multiple linear regression analysis. Thermal pain threshold was the only QST variable significantly related to the severity of neuropathic pain symptoms. The present study provides preliminary evidence that QST is a reliable and valid adjunct measurement strategy for quantifying the neurological dysfunction associated with neuropathic pain in persons with SCI.

Entities:  

Mesh:

Year:  2009        PMID: 19533521

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  20 in total

Review 1.  Can quantitative sensory testing move us closer to mechanism-based pain management?

Authors:  Yenisel Cruz-Almeida; Roger B Fillingim
Journal:  Pain Med       Date:  2013-09-06       Impact factor: 3.750

2.  Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy.

Authors:  Elisabeth G Vichaya; Xin Shelley Wang; Jessica A Boyette-Davis; Tito R Mendoza; Zijing He; Sheeba K Thomas; Nina Shah; Loretta A Williams; Charles S Cleeland; Patrick M Dougherty
Journal:  Cancer Chemother Pharmacol       Date:  2013-03-31       Impact factor: 3.333

3.  Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing.

Authors:  W Iris Zhi; Patricia Chen; Alice Kwon; Connie Chen; Steven E Harte; Lauren Piulson; Susan Li; Sujata Patil; Jun J Mao; Ting Bao
Journal:  Breast Cancer Res Treat       Date:  2019-08-27       Impact factor: 4.872

Review 4.  Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management.

Authors:  Eva Widerström-Noga
Journal:  Drugs       Date:  2017-06       Impact factor: 9.546

5.  Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

Authors:  Kathleen A Griffith; Susan G Dorsey; Cynthia L Renn; Shijun Zhu; Mary E Johantgen; David R Cornblath; Andreas A Argyriou; Guido Cavaletti; Ingemar S J Merkies; Paola Alberti; Tjeerd J Postma; Emanuela Rossi; Barbara Frigeni; Jordi Bruna; Roser Velasco; Haralabos P Kalofonos; Dimitri Psimaras; Damien Ricard; Andrea Pace; Edvina Galie; Chiara Briani; Chiara Dalla Torre; Catharina G Faber; Roy I Lalisang; Willem Boogerd; Dieta Brandsma; Susanne Koeppen; Joerg Hense; Dawn J Storey; Simon Kerrigan; Angelo Schenone; Sabrina Fabbri; Maria Grazia Valsecchi
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

6.  Decreased spinothalamic and dorsal column medial lemniscus-mediated function is associated with neuropathic pain after spinal cord injury.

Authors:  Yenisel Cruz-Almeida; Elizabeth R Felix; Alberto Martinez-Arizala; Eva G Widerström-Noga
Journal:  J Neurotrauma       Date:  2012-08-27       Impact factor: 5.269

7.  Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations.

Authors:  Kathleen A Griffith; Darren J Couture; Shijun Zhu; Naimish Pandya; Mary E Johantgen; Guido Cavaletti; Joan M Davenport; Lori J Tanguay; Amanda Choflet; Todd Milliron; Erica Glass; Nancy Gambill; Cynthia L Renn; Susan G Dorsey
Journal:  Support Care Cancer       Date:  2013-12-21       Impact factor: 3.603

8.  Reliability and Validity of the Boston Bedside Quantitative Sensory Testing Battery for Neuropathic Pain.

Authors:  Alexandra E Koulouris; Robert R Edwards; Kathleen Dorado; Kristin L Schreiber; Asimina Lazaridou; Sharika Rajan; Jeffrey White; Jenniffer Garcia; Christopher Gibbons; Roy Freeman
Journal:  Pain Med       Date:  2020-10-01       Impact factor: 3.750

9.  von Frey anesthesiometry to assess sensory impairment after acute spinal cord injury caused by thoracolumbar intervertebral disc extrusion in dogs.

Authors:  R B Song; D M Basso; R C da Costa; L C Fisher; X Mo; S A Moore
Journal:  Vet J       Date:  2015-07-30       Impact factor: 2.688

Review 10.  Interrelationship of Neurogenic Obesity and Chronic Neuropathic Pain in Persons With Spinal Cord Injury.

Authors:  Elizabeth R Felix; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.